DE69507139D1 - Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden - Google Patents

Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden

Info

Publication number
DE69507139D1
DE69507139D1 DE69507139T DE69507139T DE69507139D1 DE 69507139 D1 DE69507139 D1 DE 69507139D1 DE 69507139 T DE69507139 T DE 69507139T DE 69507139 T DE69507139 T DE 69507139T DE 69507139 D1 DE69507139 D1 DE 69507139D1
Authority
DE
Germany
Prior art keywords
ketosteroids
delta
hydrogen
alkyl
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69507139T
Other languages
English (en)
Other versions
DE69507139T2 (de
Inventor
Philip Weintraub
Cynthia Gates
Michael Angelastro
Timothy Curran
Gary Flynn
Chi-Hsin King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69507139D1 publication Critical patent/DE69507139D1/de
Application granted granted Critical
Publication of DE69507139T2 publication Critical patent/DE69507139T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69507139T 1994-05-02 1995-04-11 Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden Expired - Fee Related DE69507139T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23143394A 1994-05-02 1994-05-02
PCT/US1995/004399 WO1995029932A1 (en) 1994-05-02 1995-04-11 Process for the preparation of 4-amino-δ4-3-ketosteroids via 4-nitro-δ4-3-ketosteroids

Publications (2)

Publication Number Publication Date
DE69507139D1 true DE69507139D1 (de) 1999-02-18
DE69507139T2 DE69507139T2 (de) 1999-09-30

Family

ID=22869232

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69507139T Expired - Fee Related DE69507139T2 (de) 1994-05-02 1995-04-11 Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden

Country Status (18)

Country Link
US (4) US5750744A (de)
EP (1) EP0758340B1 (de)
JP (1) JPH09512547A (de)
CN (1) CN1042540C (de)
AT (1) ATE175419T1 (de)
AU (1) AU686793B2 (de)
CA (1) CA2188760A1 (de)
DE (1) DE69507139T2 (de)
DK (1) DK0758340T3 (de)
ES (1) ES2128052T3 (de)
FI (1) FI964410A (de)
GR (1) GR3029433T3 (de)
HU (1) HUT75523A (de)
IL (1) IL113532A (de)
NO (1) NO964627L (de)
NZ (1) NZ283974A (de)
WO (1) WO1995029932A1 (de)
ZA (1) ZA953357B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP1562975A2 (de) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB892620A (en) * 1957-07-20 1962-03-28 Syntex Sa Cyclopentanophenanthrene derivatives
US3014632A (en) * 1961-03-06 1961-12-26 American Can Co Divider
US3159622A (en) * 1963-03-22 1964-12-01 Searle & Co 17 alpha-(2-carboxyethyl)-17 belta-hydroxy-6-nitroandrost-4-en-3-one gamma-lactones
GB8503940D0 (en) * 1985-02-15 1985-03-20 Erba Farmitalia 4-substituted androstendione derivatives
NZ239141A (en) * 1990-08-01 1994-04-27 Merrell Dow Pharma 4-amino-delta-4,6-steroids; preparatory processes and pharmaceutical compositions
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors

Also Published As

Publication number Publication date
IL113532A (en) 2000-02-17
US5965550A (en) 1999-10-12
EP0758340A1 (de) 1997-02-19
US5990328A (en) 1999-11-23
CN1147258A (zh) 1997-04-09
CN1042540C (zh) 1999-03-17
AU686793B2 (en) 1998-02-12
ES2128052T3 (es) 1999-05-01
JPH09512547A (ja) 1997-12-16
NZ283974A (en) 1998-02-26
HUT75523A (en) 1997-05-28
HU9603035D0 (en) 1997-01-28
DK0758340T3 (da) 1999-08-30
AU2244995A (en) 1995-11-29
FI964410A0 (fi) 1996-11-01
US5869475A (en) 1999-02-09
US5750744A (en) 1998-05-12
EP0758340B1 (de) 1999-01-07
ZA953357B (en) 1996-01-17
IL113532A0 (en) 1995-07-31
DE69507139T2 (de) 1999-09-30
FI964410A (fi) 1996-11-01
NO964627D0 (no) 1996-11-01
GR3029433T3 (en) 1999-05-28
ATE175419T1 (de) 1999-01-15
CA2188760A1 (en) 1995-11-09
WO1995029932A1 (en) 1995-11-09
NO964627L (no) 1997-01-02

Similar Documents

Publication Publication Date Title
NZ290757A (en) Delivery of nucleic acid into a cell
DE59502595D1 (de) Polyurethanharze, verfahren zu ihrer herstellung sowie ihre verwendung in wasserverdünnbaren überzugsmitteln
ZA944884B (en) Derivatives of valproic acid amides and 2-valproenoic acid amides method of making and use thereof as anticonvulsant agent
IL86139A (en) 17-(cyclopropylamino) androst-5-en-3 ol and pharmaceutical compositions containing them, useful as c17-20 lyase inhibitors
ZA984635B (en) Orally active iron (III) chelators.
DE69507139D1 (de) Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden
ATE163423T1 (de) Verfahren zur herstellung von taurocholansäure
ATE49957T1 (de) Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel.
DE69810934D1 (de) Ribonukleosid-derivat und verfahren zu seiner herstellung
KR880012634A (ko) C_17-20리아제 억제제로서 유용한 17β-(사이클로프로필옥시)안드로스트-5-엔-3β-올 및 관련 화합물
HU9502603D0 (en) Hydroxymethyl furazane carbocyclic acid derivatives and their use in the treatment of cardio-vascular conditions
DE59202415D1 (de) Verfahren zur herstellung von 5,6-dihydroxyindolinen.
ATE44532T1 (de) Verfahren zur herstellung von pregnan-derivaten.
DE3564263D1 (en) Process for preparing azetidine derivatives and intermediates therein
ATE163638T1 (de) Verfahren zur herstellung von halogendifluoressigsäurealkylester
ATE249450T1 (de) Verfahren zur herstellung von l-ascorbinsäure
IL116646A0 (en) Antifungal fusacandins
DE59503274D1 (de) Verfahren zur herstellung von arabinonukleosiden
ZA9610040B (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds.
DE59303593D1 (de) Verfahren zur herstellung von 3-hydroxyphenylessigsäure
ATE192454T1 (de) Verfahren zur herstellung von (11beta,16beta)-21- (3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5 h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione
MX9709823A (es) Acidos fenilboronicos 4-sustituidos como estabilizantes de enzimas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee